Management of gene promoter mutations in molecular diagnostics

Clinical Chemistry

Volumn 55, Issue 4, 2009, Pages 698-708

  De Vooght, Karen M K ^a   Wijk, Richard Van ^a   Van Solinge, Wouter W ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BERNARD SOULIER DISEASE; BETA THALASSEMIA; DIAGNOSTIC PROCEDURE; FAMILIAL HYPERCHOLESTEROLEMIA; GENE LOCATION; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HEMOPHILIA B; HUMAN; MUTATIONAL ANALYSIS; POLYMORPHIC LOCUS; PROMOTER REGION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTION REGULATION; ANIMAL; BIOLOGY; DNA SEQUENCE; GENERAL ASPECTS OF DISEASE; GENETICS; METHODOLOGY; MUTATION;

ANIMALS; COMPUTATIONAL BIOLOGY; DISEASE; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; MUTATION; PROMOTER REGIONS, GENETIC; SEQUENCE ANALYSIS, DNA;

EID: 64149102324     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2008.120931     Document Type: Review

References (38)

1. Maston GA, Evans SK, Green MR. Transcriptional regulatory elements in the human genome. Annu Rev Genomics Hum Genet 2006;23:23.
2. Cosma MP. Ordered recruitment: gene-specific mechanism of transcription activation. Mol Cell 2002;10:227-36.
3. Latchman DS. Eukaryotic transcription factors. 3rd ed. London: Academic Press; 1998. 360 p.
4. Breathnach R, Chambon P. Organization and expression of eucaryotic split genes coding for proteins. Ann Rev Biochem 1981;50: 349-83.
5. Denoeud F, Kapranov P, Ucla C, Frankish A, Cas- telo R, Drenkow J, et al. Prominent use of distal 5 transcription start sites and discovery of a large number of additional exons in ENCODE regions. Genome Res 2007;17:746-59.
6. de Vooght KM, van Wijk R, van Solinge WW. GATA-1 binding sites in exon 1 direct erythroid- specific transcription of PPOX. Gene 2008;409: 83-91.
7. Zimmermann N, Colyer JL, Koch LE, Rothenberg ME. Analysis of the CCR3 promoter reveals a regulatory region in exon 1 that binds GATA-1. BMC Immunol 2005;6:7.
8. Kimura K, Wakamatsu A, Suzuki Y, Ota T, Nish- ikawa T, Yamashita R, et al. Diversification of transcriptional modulation: large-scale identifica- tion and characterization of putative alternative promoters of human genes. Genome Res 2006; 16:55-65.
9. Stenson PD, Ball EV, Mort M, Phillips AD, Shiel JA, Thomas NS, et al. Human Gene Mutation Database (HGMD): 2003 update. Hum Mutat 2003;21:577-81.
10. Rockman MV, Wray GA. Abundant raw material for cis-regulatory evolution in humans. Mol Biol Evol 2002;19:1991-2004.
11. Ladenvall P, Johansson L, Jansson JH, Jern S, Nilsson TK, Tjarnlund A, et al. Tissue-type plasminogen ac- tivator 7,351C/T enhancer polymorphism is asso- ciated with a first myocardial infarction. Thromb Haemost 2002;87:105-9.
12. Cooper DN. Human gene mutation in pathology and evolution. J Inherit Metab Dis 2002;25: 157-82.
13. Finishing the euchromatic sequence of the human genome. Nature (Lond) 2004;431:931-45.
14. Poncz M, Ballantine M, Solowiejczyk D, Barak I, Schwartz E, Surrey S. beta-Thalassemia in a Kurd- ish Jew: single base changes in the T-A-T-A box. J Biol Chem 1982;257:5994-6.
15. Hardison RC, Chui DHK, Giardine B, Riemer C, Patrinos GP, Anagnou N, et al. HbVar: a rela- tional database of human hemoglobin variants and thalassemia mutations at the globin gene server. Hum Mutat 2002;19:225-33.
16. Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, Grzelczak Z, et al. Identification of the cystic fibrosis gene: cloning and characteriza- tion of complementary DNA. Science (Wash DC) 1989;245:1066-73.
17. Bienvenu T, Lacronique V, Raymondjean M, Ca- zeneuve C, Hubert D, Kaplan JC, Beldjord C. Three novel sequence variations in the 5 up- stream region of the cystic fibrosis transmem- brane conductance regulator (CFTR) gene: two polymorphisms and one putative molecular de- fect. Hum Genet 1995;95:698-702.
18. McCarthy VA, Harris A. The CFTR gene and reg- ulation of its expression. Pediatr Pulmonol 2005; 40:1-8.
19. Knight JC. Functional implications of genetic vari- ation in non-coding DNA for disease susceptibility and gene regulation. Clin Sci (Lond) 2003;104: 493-501.
20. Wang DG, Fan JB, Siao CJ, Berno A, Young P, Sapolsky R, et al. Large-scale identification, map- ping, and genotyping of single-nucleotide poly- morphisms in the human genome. Science (Wash DC) 1998;280:1077-82.
21. Antonarakis SE, Krawczak M, Cooper DN. Disease-causing mutations in the human ge- nome. Eur J Pediatr 2000;159:S173-8.
22. Wingender E, Chen X, Hehl R, Karas H, Liebich I, Matys V, et al. TRANSFAC: an integrated system for gene expression regulation. Nucleic Acids Res 2000;28:316-9.
23. Schug J, Overton GC. TESS: Transcription element search software on the WWW.Pennsylvania: Computational Biology and Informatics Labora- tory, School of Medicine, University of Penn- sylvania; 1998. 10 p. Available from: http://www.cbil.upenn.edu/tess/techreports/1997/CBIL-TR-1997-1001-v0.0.pdf.
24. Fogel GB, Weekes DG, Varga G, Dow ER, Cra- ven AM, Harlow HB, et al. A statistical analysis of the TRANSFAC database. Biosystems 2005; 81:137-54.
25. Wray GA, Hahn MW, Abouheif E, Balhoff JP, Pizer M, Rockman MV, Romano LA. The evolution of transcriptional regulation in eukaryotes. Mol Biol Evol 2003;20:1377-419.
26. Alam J, Cook JL. Reporter genes: application to the study of mammalian gene transcription. Anal Biochem 1990;188:245-54.
27. Nobrega MA, Ovcharenko I, Afzal V, Rubin EM. Scanning human gene deserts for long-range en- hancers. Science (Wash DC) 2003;302:413.
28. Carey M, Smale ST. Transcriptional regulation in eukaryotes: concepts, strategies, and techniques. New York: Cold Spring Harbor Laboratory Press; 2000. 640 p.
29. Garner MM, Revzin A. A gel electrophoresis method for quantifying the binding of proteins to specific DNA regions: application to compo- nents of the Escherichia coli lactose operon regulatory system. Nucleic Acids Res 1981;9: 3047-60.
30. Orlando V, Strutt H, Paro R. Analysis of chromatin structure by in vivo formaldehyde cross-linking. Methods 1997;11:205-14.
31. Wray GA. The evolutionary significance of cis- regulatory mutations. Nat Rev Genet 2007;8: 206-16.
32. Wasserman WW, Sandelin A. Applied bioinfor- matics for the identification of regulatory ele- ments. Nat Rev Genet 2004;5:276-87.
33. Ludlow LB, Schick BP, Budarf ML, Driscoll DA, Zackai EH, Cohen A, Konkle BA. Identification of a mutation in a GATA binding site of the platelet glycoprotein Ib promoter resulting in the Bernard-Soulier syndrome. J Biol Chem 1996;271: 22076-80.
34. Manco L, Ribeiro ML, Máximo V, Almeida H, Costa A, Freitas O, et al. A new PKLR gene mutation in the R-type promoter region af- fects the gene transcription causing pyruvate kinase deficiency. Br J Haematol 2000;110: 993-7.
35. Van Wijk R, Van Solinge WW, Nerlov C, Beutler E, Gelbart T, Rijksen G, Nielsen FC. Disruption of a novel regulatory element in the erythroid-specific promoter of the human PKLR gene causes severe pyruvate kinase deficiency. Blood 2003;101: 1596-602.
36. Crossley M, Brownlee GG. Disruption of a C/EBP binding site in the factor IX promoter is associ- ated with haemophilia B. Nature (Lond) 1990; 345:444-6.
37. Reijnen MJ, Sladek FM, Bertina RM, Reitsma PH. Disruption of a binding site for hepatocyte nu- clear factor 4 results in hemophilia B Leyden. Proc Natl Acad SciUSA 1992;89:6300-3.
38. Galas DJ, Schmitz A. DNAse footprinting: a sim- ple method for the detection of protein-DNA binding specificity. Nucleic Acids Res 1978;5: 3157-70.